Dermata Therapeutics, Inc. Profile Avatar - Palmy Investing

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate…

Biotechnology
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Dermata Therapeutics, Inc. (DRMA) to it's peer group.

Peer Group
Loading...
End of DRMA's Analysis
CIK: 1853816 CUSIP: 249845108 ISIN: US2498453065 LEI: - UEI: -
Secondary Listings
DRMA has no secondary listings inside our databases.